Cipla signs definitive agreements for investment in iCaltech Innovations

22 Jul 2025 Evaluate

Cipla has signed definitive agreements for investment in Optionally Convertible Preference Shares of iCaltech Innovations, subject to completion of certain conditions. iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core focus on respiratory care. Strategic partnerships remain central to Cipla’s innovation engine, as the company continues to expand its digital, devices and diagnostics offerings and build on its legacy of lung leadership. 

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1505.05 8.70 (0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×